Bambuterol (INN, marketed by AstraZeneca under the trade names Bambec and Oxeol) is a long acting beta-adrenoceptor agonist used in the treatment of asthma. It is a prodrug of terbutaline. Dosage : children : 4 to 5 mg once daily - for adults : 10mg once daily. Availability of bambuterol : 4mg, 5mg & 10 mg. tablets. Breast Feeding : It is not known whether bambuterol passes into breast milk. Pregnancy : Risks - Benefits ratio must be evaluated by a qualified medical practioner.

PropertyValue
dbpedia-owl:Drug/atcPrefix
  • R03
dbpedia-owl:Drug/atcSuffix
  • CC12
dbpedia-owl:Drug/casNumber
  • 81732-46-9
dbpedia-owl:Drug/iupacName
  • 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diyl bis(dimethylcarbamate)
dbpedia-owl:Drug/pubchem
  • 54766
dbpedia-owl:atcPrefix
  • R03
dbpedia-owl:atcSuffix
  • CC12
dbpedia-owl:casNumber
  • 81732-46-9
dbpedia-owl:iupacName
  • 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diyl bis(dimethylcarbamate)
dbpedia-owl:pubchem
  • 54766
dbpedia-owl:thumbnail
dbpprop:abstract
  • Bambuterol (INN, marketed by AstraZeneca under the trade names Bambec and Oxeol) is a long acting beta-adrenoceptor agonist used in the treatment of asthma. It is a prodrug of terbutaline. Dosage : children : 4 to 5 mg once daily - for adults : 10mg once daily. Availability of bambuterol : 4mg, 5mg & 10 mg. tablets. Breast Feeding : It is not known whether bambuterol passes into breast milk. Pregnancy : Risks - Benefits ratio must be evaluated by a qualified medical practioner. side effects of bambuterol are fatigue, nausea, palpitations, headache, dizziness and termor Drug Interactions : Succinylcholine, MOIs - Monomine oxidase inhibitors, b-blockers, corticosteroids, diuretics, muscles relaxants, sympathomimetic xenathine derivatives. Contra-indications: Hepatic impairment, liver cirrhosis or severely impaired liver function. Special precautions: Dose should be reduced in patients with severely impaired renal function - patients with genetic deficiencies of plasma cholinesterase - patients with severe ischamic heart disease.
dbpprop:atcPrefix
  • R03
dbpprop:atcSuffix
  • CC12
dbpprop:bioavailability
  • 20
dbpprop:c
  • 18 (xsd:integer)
dbpprop:casNumber
  • 81732-46-9
dbpprop:eliminationHalfLife
  • 13 hours (bambuterol) 21 hours (terbutaline)
dbpprop:excretion
dbpprop:h
  • 29 (xsd:integer)
dbpprop:hasPhotoCollection
dbpprop:iupacName
  • 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diyl bis(dimethylcarbamate)
dbpprop:legalStatus
  • Rx-only
dbpprop:metabolism
dbpprop:molecularWeight
  • 367.44 g/mol
dbpprop:n
  • 3 (xsd:integer)
dbpprop:o
  • 5 (xsd:integer)
dbpprop:pregnancyCategory
  • Unknown
dbpprop:pubchem
  • 54766 (xsd:integer)
dbpprop:routesOfAdministration
  • Oral
dbpprop:smiles
  • O=C(Oc1cc(cc(c1)OC(=O)N(C)C)C(O)CNC(C)(C)C)N(C)C
dbpprop:verifiedrevid
  • 246571927 (xsd:integer)
dbpprop:wikiPageUsesTemplate
rdf:type
rdfs:comment
  • Bambuterol (INN, marketed by AstraZeneca under the trade names Bambec and Oxeol) is a long acting beta-adrenoceptor agonist used in the treatment of asthma. It is a prodrug of terbutaline. Dosage : children : 4 to 5 mg once daily - for adults : 10mg once daily. Availability of bambuterol : 4mg, 5mg & 10 mg. tablets. Breast Feeding : It is not known whether bambuterol passes into breast milk. Pregnancy : Risks - Benefits ratio must be evaluated by a qualified medical practioner.
rdfs:label
  • Bambuterol
owl:sameAs
skos:subject
foaf:depiction
foaf:page
is dbpprop:redirect of
is owl:sameAs of